STOCKHOLDERS EQUITY (DEFICIT) (Details 4) |
12 Months Ended |
|---|---|
|
Dec. 31, 2023
$ / shares
shares
| |
| Number of exercisable options | 244,749 |
| Weighted average exercise price exercisable | $ / shares | $ 35.52 |
| Registered Warrant | 33 | |
| Exercise price range | 5.50 |
| Number of exercisable Register warrant | 495,917 |
| Number of exercisable options | 495,917 |
| Weighted average exercise price exercisable term | 2 years 4 months 24 days |
| Weighted average exercise price exercisable | $ / shares | $ 33.00 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|